Skip to main content
. 2015 Sep 3;9:5075–5086. doi: 10.2147/DDDT.S84177

Figure 3.

Figure 3

Kaplan–Meier plot of progression-free survival based on investigator-assessed tumor response.

Abbreviations: CI, confidence interval; n/N, number of responders/number of patients analyzed; octreotide LAR, octreotide long-acting repeatable; pasireotide LAR, pasireotide long-acting release; PFS, progression-free survival.